National Cancer Institute; Notice of Closed Meetings, 62747-62748 [2016-21785]

Download as PDF Federal Register / Vol. 81, No. 176 / Monday, September 12, 2016 / Notices 260 submissions of 510(k)s for third party review per year. Proposed revisions to the currently approved information collection: DEPARTMENT OF HEALTH AND HUMAN SERVICES • Reporting National Cancer Institute; Amended Notice of Meeting National Institutes of Health Æ Requests for rerecognition: The Agency anticipates an average annual receipt of four applications for rerecognition for third party 510(k) review. The Agency reached this estimate by reviewing the number of existing recognized firms under the TP Review Program and anticipating the number of firms applying for rerecognition every 3 years. • Recordkeeping Æ The Agency expects TP Review Organizations to retain and maintain documentation related to recognition and rerecognition. The respondents for this information collection are private sector, for-profit firms seeking recognition and rerecognition. The draft guidance also refers to previously approved collections of information found in FDA regulations. The collections of information in 21 CFR part 807, subpart E have been approved under OMB control number 0910–0120; collections of information for the device appeals processes have been approved under OMB control number 0910–0738. V. References sradovich on DSK3GMQ082PROD with NOTICES The following references have been placed on display in the Division of Dockets Management (see ADDRESSES), and are available for viewing by interested persons between 9 a.m. and 4 p.m., Monday through Friday; they are also available electronically at https:// www.regulations.gov. FDA has verified the Web site addresses, as of the date this document publishes in the Federal Register but Web sites are subject to change over time. 1. International Medical Device Regulators Forum’s Medical Device Single Audit Program documents, available at https:// imdrf.org/documents/documents.asp. 2. FDA Draft Guidance entitled ‘‘Accreditation and Reaccreditation Process for Firms under the Third Party Review Program: Part I,’’ February 15, 2013, available at https://www.fda.gov/downloads/ MedicalDevices/ DeviceRegulationandGuidance/ GuidanceDocuments/UCM339697.pdf. Dated: September 6, 2016. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2016–21876 Filed 9–9–16; 8:45 am] BILLING CODE 4164–01–P VerDate Sep<11>2014 18:40 Sep 09, 2016 Jkt 238001 Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, October 26, 2016, 11:00 a.m. to October 26, 2016, 5:00 p.m., National Cancer Institute Shady Grove, 9609 Medical Center Drive, 4W034, Rockville, MD 20850 which was published in the Federal Register on August 25, 2016, 81 FR 58524. The meeting notice is amended to change the date of the meeting to November 15, 2016 from 11:00 a.m. to 5:00 p.m. The meeting is closed to the public. Dated: September 6, 2016. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–21786 Filed 9–9–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel R13 Conference Grant Review. Date: October 11, 2016. Time: 12:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W556, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Bratin K. Saha, Ph.D., Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 62747 Institute, 9609 Medical Center Drive, Room 7W556, Rockville, MD 20892–9750, 240– 276–6411 sahab@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (U01). Date: October 14, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W260, Rockville, MD 20892–9750 240–276–5856, nadeem.khan@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel Cooperative Agreement to Develop Targeted Agents for use with Systemic Agents Plus Radiotherapy (U01). Date: October 21, 2016. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Thomas A. Winters, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W412, Rockville, MD 20892–9750, 240–276–6386, twinters@ mail.nih.gov. Name of Committee: National Cancer Institute Initial Review Group Subcommittee F—Institutional Training and Education. Date: October 24–25, 2016. Time: 7:30 p.m. to 3:45 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Timothy C. Meeker, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W606, Rockville, MD 20892–9750, 240– 276–6464, meekert@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, NCI Clinical and Translational, R21: SEP–7. Date: October 27, 2016. Time: 10:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Caron A. Lyman, Ph.D., Chief, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W126, Rockville, MD 20892–9750, 240– 276–6348, lymanc@mail.nih.gov. E:\FR\FM\12SEN1.SGM 12SEN1 sradovich on DSK3GMQ082PROD with NOTICES 62748 Federal Register / Vol. 81, No. 176 / Monday, September 12, 2016 / Notices Name of Committee: National Cancer Institute Special Emphasis Panel Multilevel Interventions in Cancer Care Delivery. Date: October 28, 2016. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Thomas A. Winters, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W412, Rockville, MD 20892–9750, 240–276–6386, twinters@ mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Cancer Imaging, Radiotherapy, and Theranostics (R21). Date: November 2, 2016. Time: 11:00 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W554, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Christopher L. Hatch, Ph.D., Chief, Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W554, Rockville, MD 20892–9750, 240–276–6454, ch29v@nih.gov. Name of Committee: National Cancer Institute Initial Review Group, Subcommittee J—Career Development. Date: November 3, 2016. Time: 8:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W624, Rockville, MD 20892–9750, 240– 276–6132, tushar.deb@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel NCI Provocative Questions—PQ9. Date: November 9, 2016. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W034, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W242, Rockville, MD 20892–9750, 240–276–6372, zouzhiq@ mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, NCI Clinical and Translational R21: SEP–3. VerDate Sep<11>2014 18:40 Sep 09, 2016 Jkt 238001 Date: November 15, 2016. Time: 9:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W624, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W624, Rockville, MD 20892–9750, 240– 276–6132, tushar.deb@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel SBIR Bridge Awards. Date: December 7, 2016. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 4W032/034, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review Officer Research and Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W244, Rockville, MD 20892–9750, 240–276–6373, bielatk@mail.nih.gov. Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: September 6, 2016. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–21785 Filed 9–9–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; International Center of Excellence for Malaria Research (U19). Date: October 5–6, 2016. Time: 8:00 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Yong Gao, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room #3G13B, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC 9823, Rockville, MD 20892–7616, (240) 669–5048, yong.gao@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: September 2, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–21788 Filed 9–9–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel NIDCR Clinical Trials & Studies SEP. Date: October 11, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Morrison Clark Hotel, 1015 L Street NW., Washington, DC 20001. Contact Person: Crina Frincu, Ph.D., Scientific Review Officer, Scientific Review E:\FR\FM\12SEN1.SGM 12SEN1

Agencies

[Federal Register Volume 81, Number 176 (Monday, September 12, 2016)]
[Notices]
[Pages 62747-62748]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-21785]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel R13 Conference Grant Review.
    Date: October 11, 2016.
    Time: 12:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W556, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Bratin K. Saha, Ph.D., Scientific Review 
Officer, Program Coordination and Referral Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W556, Rockville, MD 20892-9750, 240-276-6411 
sahab@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Cancer Tissue Engineering Collaborative: Enabling Biomimetic 
Tissue-Engineered Technologies for Cancer Research (U01).
    Date: October 14, 2016.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W260, Rockville, MD 20892-9750 240-276-5856, 
nadeem.khan@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Cooperative Agreement to Develop Targeted Agents for use with 
Systemic Agents Plus Radiotherapy (U01).
    Date: October 21, 2016.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Thomas A. Winters, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, 9609 Medical Center Drive, Room 7W412, 
Rockville, MD 20892-9750, 240-276-6386, twinters@mail.nih.gov.

    Name of Committee: National Cancer Institute Initial Review 
Group Subcommittee F--Institutional Training and Education.
    Date: October 24-25, 2016.
    Time: 7:30 p.m. to 3:45 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Timothy C. Meeker, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W606, Rockville, MD 20892-9750, 240-276-6464, 
meekert@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI Clinical and Translational, R21: SEP-7.
    Date: October 27, 2016.
    Time: 10:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Caron A. Lyman, Ph.D., Chief, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W126, Rockville, MD 20892-9750, 240-276-6348, 
lymanc@mail.nih.gov.


[[Page 62748]]


    Name of Committee: National Cancer Institute Special Emphasis 
Panel Multilevel Interventions in Cancer Care Delivery.
    Date: October 28, 2016.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Thomas A. Winters, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, 9609 Medical Center Drive, Room 7W412, 
Rockville, MD 20892-9750, 240-276-6386, twinters@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Cancer Imaging, Radiotherapy, and Theranostics (R21).
    Date: November 2, 2016.
    Time: 11:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W554, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Christopher L. Hatch, Ph.D., Chief, Scientific 
Review Officer, Program Coordination and Referral Branch, Division 
of Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W554, Rockville, MD 20892-9750, 240-276-6454, 
ch29v@nih.gov.

    Name of Committee: National Cancer Institute Initial Review 
Group, Subcommittee J--Career Development.
    Date: November 3, 2016.
    Time: 8:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W624, Rockville, MD 20892-9750, 240-276-6132, 
tushar.deb@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel NCI Provocative Questions--PQ9.
    Date: November 9, 2016.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W034, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, 9609 Medical Center Drive, Room 7W242, 
Rockville, MD 20892-9750, 240-276-6372, zouzhiq@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI Clinical and Translational R21: SEP-3.
    Date: November 15, 2016.
    Time: 9:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W624, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W624, Rockville, MD 20892-9750, 240-276-6132, 
tushar.deb@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel SBIR Bridge Awards.
    Date: December 7, 2016.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 4W032/034, Rockville, MD 20850 (Telephone 
Conference Call).
    Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review 
Officer Research and Technology and Contract Review Branch, Division 
of Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W244, Rockville, MD 20892-9750, 240-276-6373, 
bielatk@mail.nih.gov.

Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer 
Construction; 93.393, Cancer Cause and Prevention Research; 93.394, 
Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment 
Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers 
Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, 
National Institutes of Health, HHS)

    Dated: September 6, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-21785 Filed 9-9-16; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.